ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0641

Predictive Validity of Coronary Artery Calcium Scoring in Low Risk Systemic Lupus Erythematous Patients

Katherine Chakrabarti1, Apurba Chakrabarti2, Emily Lewis2 and William McCune3, 1University of Michigan, Ann Arbor, MI, 2University of Michigan Hospital, Ann Arbor, MI, 3U Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2024

Keywords: Cardiovascular, Heart disease, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Traditionally, a coronary artery calcium (CAC) score of zero is associated with low rates (0.1-0.2% annualized risk) of major adverse cardiovascular outcomes (MACE). While systemic lupus erythematous (SLE) has previously been associated with premature coronary calcification, the predictive value of the CAC score (CACS) on long-term rates of MACE in SLE patients is unknown.

Methods: SLE patients followed at University of Michigan were prospectively identified between 2001 and 2005. SLE patients were included if they met at least 4 of the 1997 American College of Rheumatology SLE criteria, age < 55 years and had no known history of cardiovascular or cerebrovascular disease, diabetes, current smoking, or hypertension requiring more than one medication. All patients had at least one CACS measured by CT scan at time of inclusion. The primary outcome of MACE was defined as acute coronary syndrome, symptomatic heart failure, stroke, and coronary revascularization for stable coronary artery disease.

Results: Our cohort included 118 patients with SLE (mean age 37.7 +/- 9.2 years, 98% female, 84% Caucasian, 36% with hypertension, 13% with hyperlipidemia). The mean SLE activity index (SLEDAI) at time of first CAC scan was 3.8 +/- 3.6 (low to moderate disease activity). Eighty-eight patients had a baseline CACS of 0 Agatson Units (AU), 21 patients had mild CAC 1-99 AU, 3 patients had moderate CAC of 100-399 AU, and 6 patients had severe CAC >400 AU. Over an average follow-up of 16.1 +/- 6.2 years, 20 patients (17.0%) experienced a major adverse cardiovascular outcome including 10/88 (11.4%) patients with CACS of 0. A CACS of 0 compared to CACS >0 was associated with lower rates of MACE (11.4% versus 33.3%, p=0.010). After multivariable regression, CACS of zero was associated with 73% lower odds of MACE (odds ratio 0.27, 95% confidence interval 0.08-9.91, p=0.04).

Conclusion: In this single center prospective study, we observed that SLE patients experienced MACE at significant rates despite relatively low SLE disease activity at inclusion. Although a CACS of zero was associated with substantially reduced odds of MACE, a CACS of zero had a substantially lower negative predictive value in SLE patients in this study when compared to non-SLE cohorts.


Disclosures: K. Chakrabarti: None; A. Chakrabarti: None; E. Lewis: None; W. McCune: None.

To cite this abstract in AMA style:

Chakrabarti K, Chakrabarti A, Lewis E, McCune W. Predictive Validity of Coronary Artery Calcium Scoring in Low Risk Systemic Lupus Erythematous Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/predictive-validity-of-coronary-artery-calcium-scoring-in-low-risk-systemic-lupus-erythematous-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-validity-of-coronary-artery-calcium-scoring-in-low-risk-systemic-lupus-erythematous-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology